Item 1A. Risk Factors

There have been no material changes with respect to risk factors disclosed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following table provides information about the Company’s purchases of its common stock during the quarter ended June 30, 2025:


Period	Total Number of Shares Purchased	Average Price Paid per Share(1)		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value that May Yet be Purchased Under the Plans or Programs(2)
April 1, 2025 to April 30, 2025	—	$	—	—	$	489,689,272
May 1, 2025 to May 31, 2025	268,586	186.16		268,586	439,689,289
June 1, 2025 to June 30, 2025	—	—		—	439,689,289
Total	268,586	$	186.16	268,586	$	439,689,289

(1)Excludes commissions and the 1% excise tax imposed by the Inflation Reduction Act of 2022.

(2)On March 17, 2020, the Company’s Board of Directors (the “Board”) approved an increase of $500.0 million in the authorized level of repurchases of common stock. This approval is in addition to the prior repurchase authorization of the Board of $300.0 million on December 1, 2015. These authorizations have no expiration date and exclude fees, commissions, excise taxes and other expenses related to such common stock repurchases.

Previous: Item 4. Controls and Procedures · Next: Item 5. Other Information